Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

01 January 2002

Nefiracetam ameliorates associative learning impairment in the scopolamine-injectedolder rabbit.

John Green, Boris Heifets, Jonathan Pak, Michelle Pak, Diana Woodruff-Pak

Med Sci Monit 2002; 8(4): BR105-112 :: ID: 420883


BACKGROUND: The cognition-enhancing drug, nefiracetam, is in Phase IIIclinical trials to treat memory impairment in Alzheimer's disease (AD). Nefiracetam ameliorates acquisitionof delay eyeblink classical conditioning in older rabbits, a form of associative learning with strikingbehavioral and neurobiological similarities in rabbits and humans. In both species, delay eyeblink conditioningengages the septo-hippocampal cholinergic system and is disrupted when the cholinergic system is antagonized.Delay eyeblink classical conditioning is impaired in normal aging and severely disrupted in AD. MATERIAL/METHODS:To test further the efficacy of nefiracetam in an animal model that mimics some of the neurobiologicaland behavioral effects present in AD, we tested 56 older rabbits assigned to 7 treatment groups in the750 ms delay eyeblink conditioning procedure. Older rabbits were injected with 1.5 mg/kg scopolamineto simulate disruption of the cholinergic system in AD. Three doses of nefiracetam (5, 10, or 15 mg/kg)were also injected in older rabbits receiving 1.5 mg/kg scopolamine. Control groups were treated with1.5 mg/kg scopolamine + vehicle, vehicle alone, or explicitly unpaired presentations of conditioningstimuli and vehicle or 1.5 mg/kg scopolamine + 15 mg/kg nefiracetam. RESULTS: Rabbits injected with 1.5mg/kg scopolamine alone were impaired, but a dose of 15 mg/kg nefiracetam reversed significantly thebehavioral impairment. CONCLUSIONS: Nefiracetam had ameliorating effects on a task impaired in AD inan animal model of AD: older rabbits with cholinergic system antagonism.

Keywords: Aging, Association Learning, Cholinergic Antagonists, Conditioning, Eyelid, Hippocampus, Learning Disorders, Nootropic Agents, Pyrrolidinones, Reaction Time, Research Support, Non-U.S. Gov, Scopolamine, Septum Pellucidum, Specific Pathogen-Free Organisms, Stimulation, Chemical

Add Comment 0 Comments

744 4


01 December 2023 : Editorial  

Editorial: Outbreaks of Post-Pandemic Childhood Pneumonia and the Re-Emergence of Endemic Respiratory Infections

Dinah V. Parums

DOI: 10.12659/MSM.943312

Med Sci Monit 2023; 29:e943312


In Press

08 Dec 2023 : Clinical Research  

Association Between Influenza Vaccine Uptake and Health Awareness: A Cross-Sectional Questionnaire-Based St...

Med Sci Monit In Press; DOI:  

04 Dec 2023 : Animal Research  

Effects of Intrathecal Ketamine on Cerebrospinal Fluid Levels of Brain-Derived Neurotrophic Factor and Mech...

Med Sci Monit In Press; DOI:  

01 Dec 2023 : Clinical Research  

Risk Factors and Clinical Outcomes of COVID-19 Infection in Multiple Sclerosis Patients: A Retrospective St...

Med Sci Monit In Press; DOI:  

30 Nov 2023 : Review article  

Decoding the Neurological Sequelae of General Anesthesia: A Review

Med Sci Monit In Press; DOI:  

Most Viewed Current Articles

13 Nov 2021 : Clinical Research  

Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...

DOI :10.12659/MSM.932788

Med Sci Monit 2021; 27:e932788


30 Dec 2021 : Clinical Research  

Retrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis o...

DOI :10.12659/MSM.935379

Med Sci Monit 2021; 27:e935379


14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990


08 Mar 2022 : Review article  

A Review of the Potential Roles of Antioxidant and Anti-Inflammatory Pharmacological Approaches for the Man...

DOI :10.12659/MSM.936292

Med Sci Monit 2022; 28:e936292


Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750